GET THE APP
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Guafensin is an expectorant. If it is related to the physical body then guafensin will have no results. It has not been approved by the FDA for the treatment of fibromyalgia. The protocol involves three parts initially titrating the guafesin, avoiding salicylates and a low carbohydrate diet. It has been claimed that guaifenesin increases the excretion of uric acid and possibly to increase phosphate excretion.
Related journals of Guafensin Fibromyalgia
Fibromyalgia: Open Access, International Journal of Physical Medicine & Rehabilitation, Rheumatology: Current Research, Journal of Sports Medicine & Doping Studies, Journal of Yoga & Physical Therapy, Myalgia And Myositis, Skeletal Muscle Journal, Sarcopenia and Muscle, Muscle & nerve.